Glutamate transporters are essential for terminating synaptic excitation and for maintaining extracellular glutamate concentrations below neurotoxic levels. These transporters also mediate a thermodynamically uncoupled chloride flux that is activated by two of the molecules that they transport -sodium and glutamate. Five eukaryotic glutamate transporters have been cloned and identified. They exhibit -SO",, identity and this homology is even greater in the carboxyl terminal half, which is predicted to have an unusual topology. Determination of the topology shows that the carboxyl terminal part of the molecule contains several transmembrane domains that are separated by at least two re-entrant loops. In these structural elements, we have identified several conserved amino acid residues that play crucial roles in the interaction with the transporter substrates sodium, potassium and glutamate.
Introduction
Glutamate is the predominant excitatory neurotransmitter in the central nervous system. Glutamate transporters remove the transmitter from the synaptic cleft and maintain its extracellular concentrations below neurotoxic levels [ 1-51. In addition, at some synapses glutamate transporters Key words: neurotransmitter, reentrant loops, topology. 'To whom correspondence should be addressed (e-rnail kanneh(aicc.huji.ac.il).
play an important role in limiting the duration of synaptic excitation [6-91. Glutamate uptake is an electrogenic process [9-113 in which the transmitter is cotransported with three sodium ions and a proton [3, 12] , followed by countertransport of a potassium ion [13-151. Glutamate transporters also mediate a thermodynamically uncoupled chloride flux that is activated by two of the molecules they transport; sodium and glutamate [16, 17] . This indicates the existence of a tight link between gating of the anion conductance and permeation of glutamate. I t has been suggested that this capacity for enhancing chloride permeability could alter neuronal excitability [ 171.
Molecular cloning and predicted structure of glutamate transporters
Transporters for many neurotransmitters were cloned on the assumption that they are related to the y-aminobutyric acid [ 181 and noradrenaline (norepinephrine) [ 191 transporters [20-221; however, this , were cloned using different approaches. T h e former two appear to be of glial origin [23, 24, 26, 27] and the latter of neuronal origin [25, 28] , as is EAAT-4, which was cloned later [17] . Indeed, these transporters are not related to the above y-aminobutyric and noradrenaline [23-251. On the other hand, they are very similar to each other, displaying -SO"& identity and to the proton-coupled glutamate transporter from Escherichia coli and other bacteria (glt-P, [29] ) and the dicarboxylate transporter (dct-A, [30] ) of Rhizobium meliloti. In these cases the identities are approx. 25-30 ' i , . Therefore, they form a distinct family. They contain between 500 and 600 amino acids. It has been shown that this family also encodes sodium-dependent transporters, 32] 
Structure-function relationships for the glutamate transporters
Substrate-induced conformational changes in GLT-1 have been detected, as revealed by the altered accessibility of trypsin-sensitive sites [44] . These experiments indicate that lithium can occupy one of the sodium binding sites and that there are at least two transporter-glutamate bound states [44] .
T w o adjacent amino acid residues of GLT-1 that are located in transmembrane domain 7, Tyr'":' and Glu"'", appear to be involved in potassium binding and are close to one of the sodium binding sites ([45,46] ; see Figure 1 ). Because of the sequential nature of the transport process [ 13, 14, 45 ] (see also Figure 2 ), mutations in these residues cause the transporter to be locked in an obligatory exchange mode [45, 46] . R.loreoirer, Tyr."" behaves as if it is alternately accessible to either side of the membrane [47] . Analysis of GLT-1 mutants in which Ser"", located in one of the re-entrant loops, has been modified indicates that at least part of this loop is necessary for the coupling of sodium and glutamate fluxes and that it is close to the glutamate binding site [48] .
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conserved in all dicarboxylic acid transporters of the family, but is not in the small, neutral amino acid transporter, 32] , whose substrates have only a single carboxyl group. They found that mutation of ArgJi9 to Thr, which occupies the same position in ASCT-1, abolished glutamate uptake, but they noted that there may be other reasons underlying such a defect [SO] . Nevertheless, the idea of a role of the arginine in glutamate binding remained viable, especially after the subsequent cloning and sequencing of the isotransporter ASCT-2 revealed that it contains a cysteine residue at the equivalent position [33, 34] . We reasoned that mutation of this arginine in a glutamate transporter that also transports a nondicarboxylic acid substrate might leave the transport of this latter substrate intact. I t was shown that EAAT-3, the human homologue of EAAC-1, also transports cysteine. We have found that mutation of the equivalent Arg"' of EAAC-1 to a neutral or negatively-charged amino acid, completely abolishes transport of glutam am ate and D-and L-aspartate, without impairing cysteine transport. Surprisingly, this cysteine transport is electroneutral rather than electrogenic. This appears to be owing to a defective interaction with potassium [l 51. We propose that Arg"' enables the coupling of their fluxes by sequentially participating in the binding of glutamate and potassium [49] . T h e hypothetical scheme shown in Figure 2 illustrates a possible scenario whereby this may be happening. GluSi4 is the EAAC-1 equivalent of Glu4"' in GLT-1, which has been shown to be crucial for interaction of the transporter with potassium [l 51. Arg"' could interact sequentially with the endogenous Glu"' in the unloaded transporter, or with the exogenous glutamate (the substrate to be transported) in the glutamateloaded form of the transporter. After the release of glutamate in the cell, a potassium ion takes the place of the arginine cation in forming an ion pair with GIuYiJ. After translocation of the potassiumloaded transporter back to the outside, potassium dissociates and Arg"' takes its place again. In a mutant where this arginine is replaced, it is possible that Glu"' interacts with other residues of the transporter, such that the potassium ion cannot approach it any more. In this case, cysteine could enter the cell instead of glutamate. However, because of the defective interaction with potassium, the transporter would be locked in the exchange mode -only the lower half cycle would operate (Figure 2 
